www.merlintrader.com/protein-degr...
www.merlintrader.com/protein-degr...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/rigel-pharma...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/rigel-pharma...
$RIGL | 🚀Buy
Rigel Pharmaceuticals, Inc.
💵 Current price: $47.24
🎯 Avg target: $46.11
📊 Potential upside: -2.4%
Worth the risk? 🤔
#investing #stocks #StockMarket #finance #ETF
$RIGL | 🚀Buy
Rigel Pharmaceuticals, Inc.
💵 Current price: $47.24
🎯 Avg target: $46.11
📊 Potential upside: -2.4%
Worth the risk? 🤔
#investing #stocks #StockMarket #finance #ETF
https://www.merlintrader.com/rigel-pharmaceuticals-stock-hub/
https://www.merlintrader.com/rigel-pharmaceuticals-stock-hub/
✓ EXACTO · 85% fiabilidad
Análisis en Bulómetro 👉 https://bulometro.es/noticias/38140-accidentemuere-un-militar-de-la-ume-durante-las-labores-de-extincion-del-incendi
✓ EXACTO · 85% fiabilidad
Análisis en Bulómetro 👉 https://bulometro.es/noticias/38140-accidentemuere-un-militar-de-la-ume-durante-las-labores-de-extincion-del-incendi
vote.sos.ri.gov/Forms/Electi...
vote.sos.ri.gov/Forms/Electi...
https://www.stocktitan.net/news/RIGL/rigel-reports-second-quarter-2026-financial-doaxjqxbp1os.html
https://www.stocktitan.net/news/RIGL/rigel-reports-second-quarter-2026-financial-doaxjqxbp1os.html
Onco360 has been selected as a national pharmacy partner by Rigel Pharmaceuticals for VEPPANU (vepdegestrant) for treatment of ER+/HER2- advanced or metastatic breast cancer.
Selected from hundreds of headlines
Onco360 has been selected as a national pharmacy partner by Rigel Pharmaceuticals for VEPPANU (vepdegestrant) for treatment of ER+/HER2- advanced or metastatic breast cancer.
Selected from hundreds of headlines
HANNAH ALISON L. (EVP, Chief Medical Officer) reported special transactions (Non-P/S).
HANNAH ALISON L. (EVP, Chief Medical Officer) reported special transactions (Non-P/S).
Ticker: $RIGL
Company: Rigel Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
# Employees: 172
Recent Close: $40.26
52-Week High: $52.24
52-Week High Date: 11-28-2025
% Off 52-Week High: -22.94%
52-Week Low: $18.24
Ticker: $RIGL
Company: Rigel Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
# Employees: 172
Recent Close: $40.26
52-Week High: $52.24
52-Week High Date: 11-28-2025
% Off 52-Week High: -22.94%
52-Week Low: $18.24
On July 1, 2026, Rigel Pharmaceuticals, Inc. announced that Alison L. Hannah, M.D. was appointed Executive Vice President and Chief Medical Officer of the Company.
On July 1, 2026, Rigel Pharmaceuticals, Inc. announced that Alison L. Hannah, M.D. was appointed Executive Vice President and Chief Medical Officer of the Company.
Ali-Jackson Kamil (Insider) sold 2,500 shares at an average price of $35.0000 per common share. (Date: 2026-06-22)
Ali-Jackson Kamil (Insider) sold 2,500 shares at an average price of $35.0000 per common share. (Date: 2026-06-22)
Furey Raymond J. (EVP, GC, CCO & Corp Sec) reported special transactions (Non-P/S).
Furey Raymond J. (EVP, GC, CCO & Corp Sec) reported special transactions (Non-P/S).
RODRIGUEZ RAUL R (CEO, President) reported special transactions (Non-P/S).
RODRIGUEZ RAUL R (CEO, President) reported special transactions (Non-P/S).
Rojkjaer Lisa (EVP, Chief Medical Officer) reported special transactions (Non-P/S).
Rojkjaer Lisa (EVP, Chief Medical Officer) reported special transactions (Non-P/S).